$CTRM Quick recap: - it does pay dividends; - it doesn't buy back its stocks; - its free cash flow only just recently became positive (in 2023, based on the past 5 years' data); - its ROA and ROC are inconsistent. What makes me more cautious is that CTRM's stock has delivered ...